On this page, you will find information about genetic changes that were identified in UDN participants.
Sharing information on this website is not a requirement of UDN participation. Only descriptions about participants who give explicit consent will appear here.
A change in the LMNA gene was identified in two UDN participants. One participant is an 8-year-old male with a neuromuscular disorder (read full description). The other participant is an 8-year-old male with muscle weakness, hypotonia, and elevated serum creatine kinase (read full description).
Jul 20, 2020
lamin A/C
The LMNA gene encodes a member of the lamin family of protein. Lamins A and C are structural proteins that provide structure and stability to cells. Lamins A and C are supporting components of the nuclear envelope, which is the structure that surrounds the nucleus in the cells. The nuclear envelope regulates the movement of molecules into and out of the nucleus. Lamins A and C may also play a role in regulating the activity (expression) of certain genes. (MedlinePlus Genetics).
Changes in the LMNA gene have been identified in individuals with neuromuscular, cardiac, and metabolic syndromes (Maggi et al. 2016).
Changes in this gene were identified in two UDN participants.
Participant 065, an 8-year-old with a neuromuscular disorder was found to have the following de novo genetic change in the LMNA gene:
Clinicians and researchers believe this change is causing the participant’s symptoms.
Participant 169, an 8-year-old with muscle weakness, hypotonia, and elevated serum creatine kinase was found to have the following de novo genetic change in the LMNA gene:
Clinicians and researchers believe this change is causing the participant’s symptoms.
Interested in learning more about this gene or sharing what you know? Contact us!
